International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in Multiple Myeloma
With the development of new effective treatment with improved depth of responses, new response criteria have been developed to define responses that are deeper than those conventionally defined as complete response. Here are the new response categories of minimal residual disease negativity defined by the IMWG to allow for uniform reporting.